CHERINGTON CHARLES purchased 143.9% of their position (4M shares) of ERNEXA THERAPEUTICS INC. on the open market
Open‑market purchase worth $2.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/17/2026ACC: 0001104659-26-016680
Director10% Owner
Since Mar 2021
+8M
Net shares
Net buyer
$2.00M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
8M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4M
Price / share
$0.50
Trade value
$2M
% of position
143.9%
2/10/2026
2.78M→6.78M
Total
Net shares
+4M
Net value
$2M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | P · Purchase | +4M | $0.50 | $2M | 143.9% | 2.78M | 6.78M |
| Total | +4M | $2M | ||||||
Derivative Transactions1
Warrants to Purchase Common Stock
Direct
Converts to
Common Stock
4M shares
Shares
+4M
Strike price
0.68
Held after
4M
Exercisable
—
2/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants to Purchase Common Stock Direct | Common Stock4M shares | 2/10/2026 | P · Purchase | +4M | 0.68 | — | 4M |